Sexual and reproductive health

Hormonal contraceptive methods for women at high risk of HIV and living with HIV

2014 Guidance statement


Front cover

Publication details

Number of pages: 16
Publication date: July 2014
Languages: English
WHO reference number: WHO/RHR/14.24


During 9–12 March 2014, WHO convened a meeting of the Guideline Development Group (GDG) comprising 52 individuals representing a wide range of stakeholders, for the purpose of reviewing, and where appropriate, revising its Medical eligibility criteria for contraceptive use, fourth edition (MEC) guidance. Recommendations concerning the use of hormonal contraceptive methods by women at high risk of HIV and women living with HIV, including women taking antiretroviral therapy (ART), were among the many topics reviewed at this meeting. Given the public health importance of this topic, and at the encouragement of the GDG, the World Health Organization is issuing its contraceptive eligibility guidance for women at high risk of HIV and women living with HIV, in advance of the entire guideline revision. It is anticipated that the revised fifth edition of the MEC will be completed in 2015.